NRC Health (NRC) stock
NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/3080% above fair value
$26.33−0.23 (-0.87%)
Close on Nov 16, 2026Market cap $582.41MP/E –Yield 1.97%
NRC Health r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for NRC Health
NRC Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?